Which is not a bad thing because I think it is better Peregrine concentrates on developing the platforms (oncology, viral, digital imaging, and other conditions - interferon, antibiotics alternative, animal medicine, etc whatever would be new fields where Bavi can do the job or help doing the job), rather then become a production facility for large market demands.
Leave that to the BP with their facilities or to set-up facilities world wide, their distribution nets, their marketing channels, etc.